{"entity":{"type":"insider","cik":"0001380022","url":"/insider/0001380022","json_url":"/insider/0001380022.json","name":"NARACHI MICHAEL","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":6,"first":"2012-05-29","last":"2014-09-15","span_basis":"filed_date"},"name_variants":[{"name":"NARACHI MICHAEL","source":"filing","n_filings":6,"first_seen":"2012-05-29","last_seen":"2014-09-15"}],"transactions":[{"id":6723573,"accession":"0001181431-14-031922","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-031922","line_url":"/filing/0001181431-14-031922#line-1","is_derivative":false,"issuer_cik":"0001380022","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001380022","owner_cik":"0001380022","owner_name":"NARACHI MICHAEL","owner_display_name":"NARACHI MICHAEL","owner_url":"/insider/0001380022","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":4.782,"price_display":"4.78","price_state":"stated","total_value":239100.0,"total_display":"239,100.00","total_whole":"239,100","shares_owned_after":58026.0,"shares_owned_after_display":"58,026","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-15","filed_date":"2014-09-15","scope":"insider"},{"id":6643965,"accession":"0001209191-14-007974","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-007974","line_url":"/filing/0001209191-14-007974#line-1","is_derivative":false,"issuer_cik":"0001305253","issuer_name":"Celladon Corp","issuer_ticker":"CLDN","issuer_name_source":null,"issuer_url":"/issuer/0001305253","owner_cik":"0001380022","owner_name":"NARACHI MICHAEL","owner_display_name":"NARACHI MICHAEL","owner_url":"/insider/0001380022","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":62500.0,"shares_display":"62,500","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":500000.0,"total_display":"500,000.00","total_whole":"500,000","shares_owned_after":62500.0,"shares_owned_after_display":"62,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-04","filed_date":"2014-02-06","scope":"insider"},{"id":2851260,"accession":"0001181431-12-041391","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-12-041391","line_url":"/filing/0001181431-12-041391","is_derivative":false,"issuer_cik":"0001380022","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001380022","owner_cik":"0001380022","owner_name":"NARACHI MICHAEL","owner_display_name":"NARACHI MICHAEL","owner_url":"/insider/0001380022","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":7.66,"price_display":"7.66","price_state":"stated","total_value":1149000.0,"total_display":"1,149,000.00","total_whole":"1,149,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-17","filed_date":"2012-07-19","scope":"insider","n_lines":2},{"id":3515812,"accession":"0001181431-12-040671","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-12-040671","line_url":"/filing/0001181431-12-040671#line-4","is_derivative":false,"issuer_cik":"0001380022","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001380022","owner_cik":"0001380022","owner_name":"NARACHI MICHAEL","owner_display_name":"NARACHI MICHAEL","owner_url":"/insider/0001380022","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":147100.0,"shares_display":"147,100","price_per_share":6.7,"price_display":"6.70","price_state":"stated","total_value":985570.0,"total_display":"985,570.00","total_whole":"985,570","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-13","filed_date":"2012-07-13","scope":"insider"},{"id":3515802,"accession":"0001181431-12-040671","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-040671","line_url":"/filing/0001181431-12-040671#line-2","is_derivative":false,"issuer_cik":"0001380022","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001380022","owner_cik":"0001380022","owner_name":"NARACHI MICHAEL","owner_display_name":"NARACHI MICHAEL","owner_url":"/insider/0001380022","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2900.0,"shares_display":"2,900","price_per_share":6.66,"price_display":"6.66","price_state":"stated","total_value":19314.0,"total_display":"19,314.00","total_whole":"19,314","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-12","filed_date":"2012-07-13","scope":"insider"},{"id":2502912,"accession":"0001181431-12-038582","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-12-038582","line_url":"/filing/0001181431-12-038582#line-4","is_derivative":false,"issuer_cik":"0001380022","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001380022","owner_cik":"0001380022","owner_name":"NARACHI MICHAEL","owner_display_name":"NARACHI MICHAEL","owner_url":"/insider/0001380022","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125000.0,"shares_display":"125,000","price_per_share":6.08,"price_display":"6.08","price_state":"stated","total_value":760000.0,"total_display":"760,000.00","total_whole":"760,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-29","filed_date":"2012-06-29","scope":"insider"},{"id":2502905,"accession":"0001181431-12-038582","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-038582","line_url":"/filing/0001181431-12-038582#line-2","is_derivative":false,"issuer_cik":"0001380022","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001380022","owner_cik":"0001380022","owner_name":"NARACHI MICHAEL","owner_display_name":"NARACHI MICHAEL","owner_url":"/insider/0001380022","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":5.66,"price_display":"5.66","price_state":"stated","total_value":566000.0,"total_display":"566,000.00","total_whole":"566,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-28","filed_date":"2012-06-29","scope":"insider"},{"id":2864006,"accession":"0001242616-12-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001242616-12-000013","line_url":"/filing/0001242616-12-000013#line-2","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001380022","owner_name":"NARACHI MICHAEL","owner_display_name":"NARACHI MICHAEL","owner_url":"/insider/0001380022","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500.0,"shares_display":"5,500","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":7500.0,"shares_owned_after_display":"7,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-25","filed_date":"2012-05-29","scope":"insider"},{"id":2864001,"accession":"0001242616-12-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001242616-12-000013","line_url":"/filing/0001242616-12-000013#line-1","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001380022","owner_name":"NARACHI MICHAEL","owner_display_name":"NARACHI MICHAEL","owner_url":"/insider/0001380022","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":13.5508,"price_display":"13.55","price_state":"stated","total_value":27101.6,"total_display":"27,101.60","total_whole":"27,102","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-24","filed_date":"2012-05-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001382911","name":"Orexigen Therapeutics, Inc.","url":"/issuer/0001382911","role":"Director, Officer (President and CEO)","n_filings":4,"first_seen":"2012-06-29","last_seen":"2014-09-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001305253","name":"Celladon Corp","url":"/issuer/0001305253","role":"Director","n_filings":1,"first_seen":"2014-02-06","last_seen":"2014-02-06"},{"type":"issuer","type_label":"ISSUER","cik":"0000792977","name":"AMAG PHARMACEUTICALS INC.","url":"/issuer/0000792977","role":"Director","n_filings":1,"first_seen":"2012-05-29","last_seen":"2012-05-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001380022","retrieved_at":"2026-08-27T14:27:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}